Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 5.78% is 130% above its 5-year average of 2.52%, near the high end of its 5-year range (-6.98%–5.78%).
As of the fiscal period ended Tuesday, March 31, 2026. 13.67% above its 12-month average of 5.08%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
5.78%
RETURN ON ASSETS (ROA) AVG TTM
5.08%
RETURN ON ASSETS (ROA) AVG 3Y
5.08%
RETURN ON ASSETS (ROA) AVG 5Y
2.52%
RETURN ON ASSETS (ROA) AVG 10Y
2.66%
RETURN ON ASSETS (ROA) AVG 15Y
3.19%
RETURN ON ASSETS (ROA) AVG 20Y
3.37%
CURRENT VS TTM AVG
+13.67%
CURRENT VS 3Y AVG
+13.72%
CURRENT VS 5Y AVG
+129.52%
CURRENT VS 10Y AVG
+117.44%
CURRENT VS 15Y AVG
+81.23%
CURRENT VS 20Y AVG
+71.73%
SECTOR MEDIAN · HEALTHCARE
4.97%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+16.30%
vs the sector median at left
McKesson Corporation
Market Cap
$96.59B
Return on Assets (ROA)
5.78%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$88.03B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$83.01B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$110.95B
Return on Assets (ROA)
5.16%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$78.22B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
Market Cap
$74.53B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
Market Cap
$119.48B
Return on Assets (ROA)
16.38%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$71.98B
Return on Assets (ROA)
8.27%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $96.59B | 5.78% | 5.08% | 5.08% | 2.52% |
| GSK plc (GSK)vs › | $103.20B | 7.15% | 6.85% | 11.28% | 9.07% |
| HCA Healthcare, Inc. (HCA)vs › | $88.03B | 11.30% | 10.43% | 10.23% | 10.42% |
| Elevance Health Inc. (ELV)vs › | $83.01B | 3.93% | 4.89% | 5.25% | 5.41% |
| Medtronic plc (MDT)vs › | $110.95B | 5.16% | 5.13% | 4.62% | 4.65% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.22B | 10.37% | 11.40% | 12.40% | 16.97% |
| Cigna Corporation (CI)vs › | $74.53B | 4.08% | 2.99% | 3.50% | 3.82% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $119.48B | 16.38% | 6.37% | 11.74% | 14.58% |
| Boston Scientific Corporation (BSX)vs › | $71.98B | 8.27% | 5.66% | 4.50% | 3.49% |
| Stryker Corporation (SYK)vs › | $130.80B | 7.78% | 6.88% | 7.02% | 6.41% |
ROA
5.8%
ROE
-219.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | 5.78% |
| 2025-03-31 | 4.39% |
| 2024-03-31 | 4.45% |
| 2023-03-31 | 5.71% |
| 2022-03-31 | 1.76% |
| 2021-03-31 | -6.98% |
| 2020-03-31 | 1.47% |
| 2019-03-31 | 0.06% |
| 2018-03-31 | 0.11% |
| 2017-03-31 | 8.50% |
| 2016-03-31 | 3.99% |
| 2015-03-31 | 2.74% |
| 2014-03-31 | 2.44% |
| 2013-03-31 | 3.85% |
| 2012-03-31 | 4.24% |
| 2011-03-31 | 3.66% |
| 2010-03-31 | 4.48% |
| 2009-03-31 | 3.26% |
| 2008-03-31 | 4.02% |
| 2007-03-31 | 4.02% |
| 2006-03-31 | 3.52% |
| 2005-03-31 | -0.84% |
| 2004-03-31 | 3.98% |
| 2003-03-31 | 3.87% |
| 2002-03-31 | 3.14% |
| 2001-03-31 | -0.42% |
| 2000-03-31 | 6.98% |
| 1999-03-31 | 0.93% |
| 1998-03-31 | 2.76% |
| 1997-03-31 | 2.59% |
